| SHORT COMMUNICATION |
|
| Year : 2019 | Volume
: 2
| Issue : 1 | Page : 13-17 |
|
|
Proposal for point-of-care testing of platelet-rich plasma quality
Tomoyuki Kawase1, Akira Takahashi2, Taisuke Watanabe3, Tetsuhiro Tsujino4
1 Division of Oral Bioengineering, Institute of Medicine and Dentistry, Niigata University, Niigata, Japan
2 Private Practice (Heart Dental Clinic), Kawasaki, Japan
3 Division of Anatomy and Cell Biology of the Hard Tissue, Institute of Medicine and Dentistry, Niigata University, Niigata, Japan
4 Private Practice (AAA+ Dental Clinic), Hiroshima, Japan
Correspondence Address:
Dr. Tomoyuki Kawase
Division of Oral Bioengineering, Institute of Medicine and Dentistry, Niigata University, Niigata
Japan
 Source of Support: None, Conflict of Interest: None  | 9 |
DOI: 10.4103/GFSC.GFSC_26_18
|
|
|
Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) regenerative therapy lacks evidence to make clinical decisions. This weakness cannot be addressed only by standardization of preparation protocols and devices. In this article, we have emphasized on the necessity for quality testing to obtain strong evidence supporting PRP/PRF therapy.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
